首页> 外文期刊>临床与转化肝病杂志(英文版) >Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C
【24h】

Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C

机译:慢性乙型和丙型肝炎纤维化进展的临床研究进展

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic liver diseases, such as chronic hepatitis B (CHB) and chronic hepatitis C (CHC), are characterized by the presence of liver fibrosis, which may ultimately lead to cirrhosis. The progression of fibrosis is associated with various factors. Here, we review recent advances in the study of factors related to the progression rate of CHB- and CHC-induced fibrosis. Identification of these factors and establishment of a scoring system for cirrhosis risk are particularly important for predict-ing cirrhosis development, planning individualized treatment, and preventing fibrosis progression.
机译:慢性肝病,例如慢性乙型肝炎(CHB)和慢性丙型肝炎(CHC),其特征是存在肝纤维化,最终可能导致肝硬化。纤维化的进展与多种因素有关。在这里,我们回顾与CHB和CHC诱导的纤维化进展速度有关的因素研究的最新进展。识别这些因素并建立肝硬化风险评分系统对于预测肝硬化的发展,规划个性化治疗和预防纤维化进展尤其重要。

著录项

  • 来源
    《临床与转化肝病杂志(英文版)》 |2014年第4期|222-227|共6页
  • 作者单位

    Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;

    Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;

    Department of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号